SCHEMBL34723

SCHEMBL34723

[CH2]Cc1ccccc1[N+](=O)[O-]

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.64
TSHR P16473 1/20 0.64
HPGD P15428 1/20 0.58
HTT P42858 1/20 0.49
HSD17B10 Q99714 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
RECQL P46063 1/20 0.47
TDP1 Q9NUW8 2/20 0.46
ACHE P22303 1/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C19 P33261 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1802353 0.85 ALDH1A1 (0.62) ALDH1A1TSHRHPGDHTTHSD17B10
SCHEMBL3202573 0.84 ALDH1A1 (0.72) ALDH1A1TSHRHPGDHTTHSD17B10
SCHEMBL2493128 0.83 ALDH1A1 (0.64) ALDH1A1TSHRHPGDHTTHSD17B10
SCHEMBL301933 0.82 ALDH1A1 (0.69) ALDH1A1TSHRHPGDHTTHSD17B10
SCHEMBL9723891 0.82 TSHR (0.53) ALDH1A1TSHRHPGDHTTHSD17B10
SCHEMBL3028940 0.82 ALDH1A1 (0.58) ALDH1A1TSHRHPGDHTTHSD17B10
Ethylene SCHEMBL27394641 0.81 ALDH1A1 (0.62) ALDH1A1TSHRHPGDHTTHSD17B10
SCHEMBL7289593 0.80 ALDH1A1 (0.56) ALDH1A1TSHRHPGDHTTHSD17B10
SCHEMBL10679746 0.80 ALDH1A1 (0.52) ALDH1A1TSHRHPGDHSD17B10L3MBTL1
SCHEMBL3841885 0.80 TDP1 (0.64) ALDH1A1TSHRHPGDHSD17B10L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1098 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118048375-A Light-sensitive degradable positive plasmid, construction method and application 郑州纳克智造生物科技有限公司 2024-05-17 CN claimed
EP-4168778-A1 METHOD FOR LOCATING INDIVIDUAL MOLECULES OF A DYE IN A SPECIMEN AND FOR GENERATING HIGH-RESOLUTION IMAGES OF A STRUCTURE IN A SPECIMEN Abberior Instruments GmbH (DE) 2023-04-26 EP claimed
US-20230120931-A1 METHOD FOR LOCALIZING SINGLE MOLECULES OF A DYE IN A SAMPLE AND FOR GENERATING HIGH-RESOLUTION IMAGES OF STRUCTURE IN A SAMPLE ABBERIOR INSTRUMENTS GMBH (DE) 2023-04-20 US claimed
US-11235330-B2 Hydrogel membrane and methods for selective retrieval of microbial targets KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2022-02-01 US claimed
WO-2021259967-A1 METHOD FOR LOCATING INDIVIDUAL MOLECULES OF A DYE IN A SPECIMEN AND FOR GENERATING HIGH-RESOLUTION IMAGES OF A STRUCTURE IN A SPECIMEN ABBERIOR INSTRUMENTS GMBH (DE) 2021-12-30 WO claimed
US-20210255074-A1 Degradable Microsphere and Use Thereof TSINGHUA UNIVERSITY (CN) 2021-08-19 US claimed
EP-3808786-A1 DEGRADABLE MICROSPHERE AND USE THEREOF Tsinghua University (CN) 2021-04-21 EP claimed
WO-2020247927-A1 NOVEL SYSTEMS, METHODS AND COMPOSITIONS FOR THE DIRECT SYNTHESIS OF STICKY ENDED POLYNUCLEOTIDES THE REGENTS OF THE UNIVERSITY OF COLORADO A BODY CORPORATE (US) 2020-12-10 WO claimed
US-20200330984-A1 HYDROGEL MEMBRANE AND METHODS FOR SELECTIVE RETRIEVAL OF MICROBIAL TARGETS NATIONAL SCIENCE FOUNDATION 2020-10-22 US claimed
EP-3565484-A1 METHODS FOR IMPLANTING AND REVERSING STIMULI-RESPONSIVE IMPLANTS Contraline, Inc. (US) 2019-11-13 EP claimed
US-5981207-A ENZYME SUBSTRATE WHICH IS DEACTIVATED BY PHOTOLYTICALLY CLEAVABLE CAGING GROUP; FOR CELL-BASED CHEMILUMINESCENT DRUG SCREENING PHARMACOPEIA, INC. (US) 1999-11-09 US claimed
EP-0700378-A1 COMPOUNDS WHICH RELEASE NITRIC OXIDE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1996-03-13 EP claimed
EP-0700378-A4 COMPOUNDS WHICH RELEASE NITRIC OXIDE UNIV CALIFORNIA (US) 1996-01-22 EP claimed
CN-1028172-C Process for preparing mono-N-alkylated polyazamacrocycles DOW CHEMICAL CO (US) 1995-04-12 CN claimed
US-5374710-A Compounds which release nitric oxide upon illumination REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1994-12-20 US claimed
WO-1994027957-A1 COMPOUNDS WHICH RELEASE NITRIC OXIDE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1994-12-08 WO claimed
US-5294618-A Psychological disorders MERCK SHARP & DOHME LIMITED (GB) 1994-03-15 US claimed
EP-0410535-A2 Octahydrobenzisoquinoline derivatives as antipsychotic agents MERCK SHARP & DOHME LTD. (GB) 1991-01-30 EP claimed
US-4822893-A Production of substituted 1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acids AMERICAN HOME PRODUCTS (US) 1989-04-18 US claimed
US-4254031-A Synthesis for the preparation of tetracyclic compounds AKZONA INCORPORATED (US) 1981-03-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210255074-A1 Degradable Microsphere and Use Thereof STUB1, PSMD14, ACP1 ALDH1A1 3389/4885TSHR 3153/4885HPGD 3491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.